<DOC>
	<DOCNO>NCT02956408</DOCNO>
	<brief_summary>Vitamin D deficiency common general population United States , common overweight obese child . Additionally , vitamin D level inversely correlate body mass index , hypertension , inflammatory marker insulin resistance . There currently clear guideline regard vitamin D replacement obese otherwise healthy child . The Endocrine Society recommend child vitamin D deficiency take 2000 IU day least 6 week ; however , state obese child may need 2-3 time dose order reach sufficient level . The goal study : 1 . To determine prevalence vitamin D sufficiency ( &gt; 30 ng/mL ) , insufficiency ( 21-29 ng/mL ) ; deficiency ( 10-19 ng/mL ) severe vitamin D deficiency ( &lt; 10 ng/dL ) obese pediatric population ( 2-11 year ) measure 25-hydroxyvitamin D. 2 . To determine vitamin D level correlate percentage body fat bioelectrical impedance analysis and/or visceral fat waist circumference child age 5 - 11 year . 3 . To observe effect vitamin D replacement obese child vitamin D deficiency use two different replacement dosage level recommend Endocrine Society three month : 2000 IU day ( general pediatric dose ) v 6000 IU day ( suggest obesity dose ) child age 5 - 11 year . 4 . To measure vitamin D level , bone marker , inflammatory marker vitamin D bind protein vitamin D supplementation child age 5 - 11 year . Analysis stratify degree obesity ( Class I , Class II , Class III ) season .</brief_summary>
	<brief_title>Efficacy Vitamin D Supplementation Obese Children</brief_title>
	<detailed_description>Study subject obese child age 2 11 year see FIT ( Families Improving Health Together ) program . As part routine care , patient see FIT program weight measure near 0.1 kilogram digital floor scale , stature wall-mounted stadiometer waist circumference measurement near 0.1 centimeter . BMI calculate weight kilogram , divide height meter square ( kg/m2 ) . Waist circumference measure tape measure uppermost lateral border hip crest ( ilium ) . Percentage body fat approximated bioelectrical impedance analysis . All patient 25-hydroxyvitamin D measure , send Esoterix Labs ( Calabasas Hills , CA ) run high-pressure liquid chromatography/tandem mass spectrometry ( HPLC/MS-MS ) . Other baseline lab draw include glucose , insulin , hemoglobin A1c , lipid panel , hepatic function panel basic metabolic panel . Blood initial visit bank future research laboratory test part overall goal FIT program . The research lab run include vitamin D binding protein , osteocalcin , c-telopeptide , P1NP , PTH , IL-6 TNF-alpha . Vitamin D prevalence information baseline lab anthropometrics obtain patient agree participate study ; however , bioelectrical impedance analysis perform patient 5 year . Patients age 5 11 year 25-hydroxyvitamin D 21 ng/mL invited participate vitamin D supplementation portion study . These patient treat vitamin D3 supplementation either 2000 IU day 6000 IU day . Dose determine set dose schedule . Each provider assign dose schedule dose schedule change every 3 month 2 year . The dosing schedule find study document section . This study design intend minimize bias base provider season . Eligible patient agree participate study purchase prescribe dose vitamin D3 , counter medication . Vitamin D3 supply counter drop , liquid , chewable tablet , gummies , tablet capsule parent select form easy child take . They supply u picture vitamin D3 label ensure take appropriate dose form vitamin D. They take prescribe dose every day three month . Patients get weekly reminder call ensure take supplement prescribe . At end three month return schedule clinic appointment . Weight , height , waist circumference percentage body fat measure lab redrawn include 25-hydroxyvitamin D glucose , insulin , hemoglobin A1c , lipid panel , hepatic function panel basic metabolic panel research lab describe draw well . At end 3 month vitamin D 21 ng/mL advise take vitamin D 1000 IU day ; vitamin D continue 21 ng/mL advise continue current dose vitamin D. We expect see average 8 new patient per week expect least 50 % vitamin D level 21 ng/mL age 5 11 year . Over two year amount 416 prospective study subject . Dosages select base Endocrine Society Clinical Practice Guidelines ( 2011 ) , state child vitamin D deficiency treat 2000 IU vitamin D day ; however obese child treat 2-3 time amount . In total expect enroll 192 subject two year intervention portion trial ( 5 - 11 year ) expect enroll total 400 subject observational portion ( prevalence association lab test ) . Exclusion criterion include follow : Underlying disorder bone metabolism , chronic renal failure , chronic steroid treatment ( oral , inhaled intranasal ) , current vitamin D supplementation find daily multivitamin .</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Obesity , Morbid</mesh_term>
	<mesh_term>Pediatric Obesity</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Enrolled FIT clinic Columbia University Medical Center Ages 511 obesity Underlying disorder bone metabolism chronic renal failure chronic steroid treatment current vitamin D supplementation find daily multivitamin</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Obesity</keyword>
	<keyword>Pediatrics</keyword>
	<keyword>Vitamin D deficiency</keyword>
</DOC>